Cover Image
Market Research Report

Transcatheter Mitral Valves Implantation (TMVI) - Medical Devices Pipeline Assessment, 2018

Published by GlobalData Product code 646100
Published Content info 101 Pages
Delivery time: 1-2 business days
Price
Back to Top
Transcatheter Mitral Valves Implantation (TMVI) - Medical Devices Pipeline Assessment, 2018
Published: June 8, 2018 Content info: 101 Pages
Description

GlobalData's Medical Devices sector report, "Transcatheter Mitral Valves Implantation (TMVI) - Medical Devices Pipeline Assessment, 2018" provides an overview of Transcatheter Mitral Valves Implantation (TMVI) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transcatheter Mitral Valves Implantation (TMVI) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transcatheter Mitral Valves Implantation (TMVI) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Mitral Valves Implantation (TMVI) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Mitral Valves Implantation (TMVI) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME0598EPD

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 Transcatheter Mitral Valves Implantation (TMVI) Overview 8

3 Products under Development 9

  • 3.1 Transcatheter Mitral Valves Implantation (TMVI) - Pipeline Products by Stage of Development 9
  • 3.2 Transcatheter Mitral Valves Implantation (TMVI) - Pipeline Products by Territory 10
  • 3.3 Transcatheter Mitral Valves Implantation (TMVI) - Pipeline Products by Regulatory Path 11
  • 3.4 Transcatheter Mitral Valves Implantation (TMVI) - Pipeline Products by Estimated Approval Date 12
  • 3.5 Transcatheter Mitral Valves Implantation (TMVI) - Ongoing Clinical Trials 13

4 Transcatheter Mitral Valves Implantation (TMVI) - Pipeline Products under Development by Companies 14

  • 4.1 Transcatheter Mitral Valves Implantation (TMVI) Companies - Pipeline Products by Stage of Development 14
  • 4.2 Transcatheter Mitral Valves Implantation (TMVI) - Pipeline Products by Stage of Development 15

5 Transcatheter Mitral Valves Implantation (TMVI) Companies and Product Overview 16

  • 5.1 4C Medical Technologies Inc Company Overview 16
    • 5.1.1 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.2 Annulon Company Overview 17
    • 5.2.1 Annulon Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.3 Cephea Valve Technologies, Inc. Company Overview 18
    • 5.3.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.4 Colibri Heart Valve, LLC Company Overview 19
    • 5.4.1 Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.5 Daidalos Solutions BV Company Overview 20
    • 5.5.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.6 Direct Flow Medical Inc (Inactive) Company Overview 21
    • 5.6.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.7 Edwards Lifesciences Corp Company Overview 22
    • 5.7.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.8 Emory University Company Overview 32
    • 5.8.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.9 HighLife SAS Company Overview 33
    • 5.9.1 HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.10 LivaNova PLC Company Overview 36
    • 5.10.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.11 Medtronic plc Company Overview 39
    • 5.11.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.12 Micro Interventional Devices, Inc. Company Overview 45
    • 5.12.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.13 Mitralix Ltd. Company Overview 46
    • 5.13.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.14 MitrAssist Ltd. Company Overview 47
    • 5.14.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.15 MValve Technologies Ltd. Company Overview 48
    • 5.15.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.16 NaviGate Cardiac Structures, Inc. Company Overview 51
    • 5.16.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.17 Neovasc Inc Company Overview 54
    • 5.17.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.18 Sino Medical Sciences Technology Inc Company Overview 57
    • 5.18.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.19 Trinity College Dublin Company Overview 58
    • 5.19.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.20 University College London Company Overview 59
    • 5.20.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.21 Valtech Cardio Ltd Company Overview 60
    • 5.21.1 Valtech Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.22 Venus MedTech Company Overview 63
    • 5.22.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview 63

6 Transcatheter Mitral Valves Implantation(TMVI)- Recent Developments 64

  • 6.1 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 64
  • 6.2 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 64
  • 6.3 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 67
  • 6.4 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results 67
  • 6.5 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 69
  • 6.6 Mar 07, 2018: 4C Medical's Transcatheter Mitral Valve Technology Receives First Place in Cardiovascular Research Technologies 2018 Competition 70
  • 6.7 Mar 01, 2018: 4C Medical's Novel Mitral Regurgitation Therapy to be Highlighted at CRT 2018 Meeting 71
  • 6.8 Feb 28, 2018: First Oregonian receives artificial mitral heart valve without open-heart surgery 71
  • 6.9 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 72
  • 6.10 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 74
  • 6.11 Jan 08, 2018: Neovasc Reports Tiara's Clinical Case Load Accelerating 74
  • 6.12 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 75
  • 6.13 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 76
  • 6.14 Dec 05, 2017: 4C Medical's Novel Transcatheter Mitral Valve Technology Awarded Best Technology Parade Presentation at ICI 2017 77
  • 6.15 Dec 04, 2017: 4C Medical's Novel Transcatheter Mitral Valve Technology Presented at ICI 2017 Technology Parade 78
  • 6.16 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 78
  • 6.17 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 81
  • 6.18 Nov 02, 2017: 4C Medical's Novel Transcatheter Mitral Valve Presented at TCT 2017 Shark Tank Innovation Competition 82
  • 6.19 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 83
  • 6.20 Nov 01, 2017: Medtronic Unveils Strong Early Outcomes for the Intrepid Transcatheter Mitral Valve Replacement (TMVR) System 84
  • 6.21 Oct 24, 2017: 4C Medicals Novel Mitral Regurgitation Therapy to be Presented at TCT 2017 Shark Tank Innovation Competition 85
  • 6.22 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results 85
  • 6.23 Oct 23, 2017: First Patient Treated in Landmark Transcatheter Mitral Valve Replacement Pivotal Trial 87
  • 6.24 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 88
  • 6.25 Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017 89
  • 6.26 Sep 12, 2017: Neovasc Provides Tiara Clinical Update 90
  • 6.27 Sep 01, 2017: Decision from Appeals Court upholds lower court decisions but denies injunction 91
  • 6.28 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 91
  • 6.29 Aug 03, 2017: 4C Medical's Novel Mitral Regurgitation Therapy Highlighted at CVI 2017 Innovation Summit 93
  • 6.30 Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results 94

7 Appendix 98

  • 7.1 Methodology 98
  • 7.2 About GlobalData 101
  • 7.3 Contact Us 101
  • 7.4 Disclaimer 101

List of Tables

1.1 List of Tables

  • Table 1: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Stage of Development 9
  • Table 2: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Territory 10
  • Table 3: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Regulatory Path 11
  • Table 4: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Estimated Approval Date 12
  • Table 5: Transcatheter Mitral Valves Implantation(TMVI) - Ongoing Clinical Trials 13
  • Table 6: Transcatheter Mitral Valves Implantation(TMVI) Companies - Pipeline Products by Stage of Development 14
  • Table 7: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Stage of Development 15
  • Table 8: 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 9: AltaValve - Product Status 16
  • Table 10: AltaValve - Product Description 16
  • Table 11: Annulon Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 12: Mitral Valve Replacement Device - Product Status 17
  • Table 13: Mitral Valve Replacement Device - Product Description 17
  • Table 14: Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 15: Mitral Valve Replacement Device - Product Status 18
  • Table 16: Mitral Valve Replacement Device - Product Description 18
  • Table 17: Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 18: Mitral Valve - Product Status 19
  • Table 19: Mitral Valve - Product Description 19
  • Table 20: Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 21: Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Status 20
  • Table 22: Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Description 20
  • Table 23: Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 24: Direct Flow Medical Transcatheter Mitral Valve - Product Status 21
  • Table 25: Direct Flow Medical Transcatheter Mitral Valve - Product Description 21
  • Table 26: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 27: Cardiaq Mitral Valve - Product Status 22
  • Table 28: Cardiaq Mitral Valve - Product Description 23
  • Table 29: FORTIS Mitral Transcatheter Heart Valve - Product Status 23
  • Table 30: FORTIS Mitral Transcatheter Heart Valve - Product Description 23
  • Table 31: PASCAL Transcatheter Mitral Valve Repair System - Product Status 24
  • Table 32: PASCAL Transcatheter Mitral Valve Repair System - Product Description 24
  • Table 33: Sapien 3 Heart Valve - Mitral Annular Calcification - Product Status 24
  • Table 34: Sapien 3 Heart Valve - Mitral Annular Calcification - Product Description 25
  • Table 35: SAPIEN M3 - Product Status 25
  • Table 36: SAPIEN M3 - Product Description 25
  • Table 37: Second Generation Transapical Transcatheter Mitral Valve - Product Status 26
  • Table 38: Second Generation Transapical Transcatheter Mitral Valve - Product Description 26
  • Table 39: Edwards Lifesciences Corp - Ongoing Clinical Trials Overview 27
  • Table 40: FORTIS Mitral Transcatheter Heart Valve - Early Feasibility Study of the CardiAQ-Edwards Transcatheter Mitral Valve (TMV) System for the Treatment of Moderate to Severe Mitral Regurgitation 28
  • Table 41: Cardiaq Mitral Valve - Early Feasibility Study of the CardiAQ-Edwards Transcatheter Mitral Valve (TMV) System for the Treatment of Moderate to Severe Mitral Regurgitation 29
  • Table 42: Sapien 3 Heart Valve - Mitral Annular Calcification - Surgical Implantation of Transcatheter valve in Native Mitral Annular Calcification (SITRAL) Study 30
  • Table 43: Sapien 3 Heart Valve - Mitral Annular Calcification - The Safety and Feasibility of the SAPIEN XT Transcatheter Heart Valve with NovaFlex and Ascendra Delivery Systems and SAPIEN 3 with Commander Delivery System in Patients with Symptomatic Severe Calcific Mitral Valve Disease with Severe Mitral Annular Calcification and Patients with Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery. 30
  • Table 44: PASCAL Transcatheter Mitral Valve Repair System - CE Mark Study of PASCAL Transcatheter Mitral Valve Repair System 31
  • Table 45: PASCAL Transcatheter Mitral Valve Repair System - The CLASP Study Edwards PASCAL TranScatheter Mitral Valve Repair System Study 31
  • Table 46: Emory University Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 47: MitraCath - Product Status 32
  • Table 48: MitraCath - Product Description 32
  • Table 49: HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 50: Transcatheter Mitral Valve Replacement System - Product Status 33
  • Table 51: Transcatheter Mitral Valve Replacement System - Product Description 33
  • Table 52: HighLife SAS - Ongoing Clinical Trials Overview 34
  • Table 53: Transcatheter Mitral Valve Replacement System - HighLife Transcatheter Mitral Valve Replacement System for Severe Mitral Regurgitation in Patients at High Surgical Risk 35
  • Table 54: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 55: Caisson TMVR System - Product Status 36
  • Table 56: Caisson TMVR System - Product Description 36
  • Table 57: LivaNova PLC - Ongoing Clinical Trials Overview 37
  • Table 58: Caisson TMVR System - Percutaneous Mitral Valve Replacement Evaluation Utilizing IDE Early Feasibility Study (PRELUDE) 38
  • Table 59: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 60: Intrepid Transcatheter Mitral Valve Replacement - Product Status 39
  • Table 61: Intrepid Transcatheter Mitral Valve Replacement - Product Description 40
  • Table 62: TCV - Mitral - Product Status 40
  • Table 63: TCV - Mitral - Product Description 40
  • Table 64: Twelve Transcatheter Mitral Valve Replacement System - Product Status 41
  • Table 65: Twelve Transcatheter Mitral Valve Replacement System - Product Description 41
  • Table 66: Medtronic plc - Ongoing Clinical Trials Overview 42
  • Table 67: Twelve Transcatheter Mitral Valve Replacement System - Evaluation of Safety and Performance of the Twelve Transcatheter Mitral Valve Replacement System in Patients with Severe, Symptomatic Mitral Regurgitation 43
  • Table 68: Intrepid Transcatheter Mitral Valve Replacement - Transcatheter Mitral Valve Replacement with the Medtronic Intrepid TMVR System in Patients with Severe Symptomatic Mitral Regurgitation - APOLLO Trial 44
  • Table 69: Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 70: Endovalve - Product Status 45
  • Table 71: Endovalve - Product Description 45
  • Table 72: Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 73: MAESTRO - Product Status 46
  • Table 74: MAESTRO - Product Description 46
  • Table 75: MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 76: MitrAssist Valve - Product Status 47
  • Table 77: MitrAssist Valve - Product Description 47
  • Table 78: MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 79: MValve Docking System - Product Status 48
  • Table 80: MValve Docking System - Product Description 48
  • Table 81: MValve Technologies Ltd. - Ongoing Clinical Trials Overview 49
  • Table 82: MValve Docking System - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve 50
  • Table 83: NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 84: Navi Mitral Valved Stent - Product Status 51
  • Table 85: Navi Mitral Valved Stent - Product Description 51
  • Table 86: NaviGate Cardiac Structures, Inc. - Ongoing Clinical Trials Overview 52
  • Table 87: Navi Mitral Valved Stent - Navi Valved Stent for Correction of Severe Functional Mitral Regurgitation (FMR) 53
  • Table 88: Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 89: Tiara Transcatheter Mitral Valve - Product Status 54
  • Table 90: Tiara Transcatheter Mitral Valve - Product Description 54
  • Table 91: Neovasc Inc - Ongoing Clinical Trials Overview 55

List of Figures

1.2 List of Figures

  • Figure 1: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Stage of Development 9
  • Figure 2: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Territory 10
  • Figure 3: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Regulatory Path 11
  • Figure 4: Transcatheter Mitral Valves Implantation(TMVI) - Pipeline Products by Estimated Approval Date 12
  • Figure 5: Transcatheter Mitral Valves Implantation(TMVI) - Ongoing Clinical Trials 13
Back to Top